Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition

NCT03284593 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

199

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: intensive chemotherapy
DRUG: Azacitidine

Sponsor

University Hospital, Toulouse